Get started
Author

Ana Ma Lacosta

Observed names: A.M. Lacosta, AM Lacosta, Ana M Lacosta, Ana M. Lacosta, Ana María Lacosta
Institution: Grifols (Spain)
OpenAlex ID: A5025824466
The chick embryo appears as a natural model for research in beta-amyloid precursor protein processing
2005 · J.A. Carrodeguas, A. Rodolosse, et al. · Neuroscience · 34
Novel expression patterns of Pax3/Pax7 in early trunk neural crest and its melanocyte and non‐melanocyte lineages in amniote embryos
2005 · Ana Ma Lacosta, Pedro Muniesa, et al. · Pigment Cell Research · 31
Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma
2016 · Virginia Pérez-Grijalba, Noelia Fandos, et al. · Journal of Alzheimer s Disease · 27
PDF
Pax7 identifies neural crest, chromatophore lineages and pigment stem cells during zebrafish development
2007 · Ana M. Lacosta, Jesus Canudas, et al. · The International Journal of Developmental Biology · 23
PDF
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double‐blind, placebo‐controlled phase 2 study
2025 · María Pascual‐Lucas, Ana María Lacosta, et al. · Alzheimer s & Dementia · 10
PDF
O2‐03‐05: Beta‐amyloid‐17 is a major beta‐amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value
2012 · Virginia Pérez, Leticia Sarasa, et al. · Alzheimer s & Dementia · 9
AB1601 topline results – Phase 2 study of ABvac40 in patients with amnestic mild cognitive impairment (a‐MCI) or very mild Alzheimer’s Disease (Vm‐AD).
2022 · Elisabet Molina, Sergio Castillo, et al. · Alzheimer s & Dementia · 4
Safety, tolerability and immunogenicity of an active anti‐Aβ40 vaccine (ABvac40) in patients with amnestic mild cognitive impairment (A‐MCI) or very mild alzheimer’s disease (VM‐AD): A randomized, double‐blind, placebo‐controlled, phase II trial
2020 · Elisabet P. Molina, Pedro Pesini, et al. · Alzheimer s & Dementia · 4
Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old
2018 · Gorka Fernández-Eulate, Ainhoa Alberro, et al. · Frontiers in Aging Neuroscience · 4
PDF
AB1601 Phase 2 Study of ABvac40, an Anti‐Aβ40 Vaccine: Safety and Immunogenicity of a Cross‐Over Extension
2023 · María Pascual‐Lucas, Ana María Lacosta, et al. · Alzheimer s & Dementia · 3
PDF
P2‐123: The deposition of Aß40 in the brain is pathognomonic for Alzheimer‐type dementia in Down syndrome
2009 · Pedro Pesini, Ana M. Lacosta, et al. · Alzheimer s & Dementia · 3
Meaningful Clinical Impact of ABvac40 in Early‐Stage Alzheimer’s Disease: Results from the AB1601 Phase 2 Study
2025 · María Pascual‐Lucas, Ana María Lacosta, et al. · Alzheimer s & Dementia · 2
PDF
[P4–384]: ANTI‐AβX‐40 ANTIBODIES EXERT NEUROPROTECTIVE EFFECT AGAINST Aβ‐OLIGOMER TOXICITY
2017 · María Montañés, Ivan Marcos, et al. · Alzheimer s & Dementia · 1
P3‐257: Immunization of dogs with C‐terminal sequences of beta‐amyloid protein is safe and depletes the protein from the blood
2009 · Pedro Pesini, Ana Ma Lacosta, et al. · Alzheimer s & Dementia · 1
Developmental spatiotemporal expression of Alzheimer beta APP isoforms in the chick embryo
2001 · L Dominguez, V Garza, et al. · The International Journal of Developmental Biology · 1
Long‐term safety and immunogenicity of ABvac40 active immunotherapy in mild cognitive impairment and very mild Alzheimer's disease: Results from AB1601 phase 2 extension study
2026 · María Pascual‐Lucas, Ana María Lacosta, et al. · Alzheimer s & Dementia
Intracellular Amyloid Precursor Protein pathology: an unrecognized neuropathological hallmark of Alzheimer's disease
2025 · Sonia Sirisi Dolcet, Érika Sánchez‐Aced, et al. · Alzheimer s & Dementia
PDF
P4‐189: ABVAC40 TREATMENT IN DOGS INDUCES SPECIFIC ANTIBODY RESPONSE AND INCREMENT OF Aβ40 LEVELS IN PLASMA
2018 · Ana M. Lacosta, Noelia Fandos, et al. · Alzheimer s & Dementia
O1‐10‐03: an Active Anti‐AB40 Vaccine (ABVAC40) Proved to be Safe and Immunogenic in the Phase i Clinical Trial
2016 · Ana M. Lacosta, Virginia Pérez-Grijalba, et al. · Alzheimer s & Dementia
P2‐168: Early diagnosis and preventive treatment of Alzheimer's with isoform‐specific Aβ antibodies
2010 · Pedro Pesini, Inmaculada Monleón, et al. · Alzheimer s & Dementia
P4‐157: Neurofibrillary tangles of Aβ40 in Alzheimer brains
2008 · Pedro Pesini, Ana M. Lacosta, et al. · Alzheimer s & Dementia
PDF
Works count: 21
Citation count: 157
H-index: 6
I10-index: 5
Year
Topic
Type